For example, this method has been clinically used to validate the effects of PTGER4/SHOX2 genes in lung cancer, as well as the GSTP1 and GSTP1 genes in prostate cancer (Roy and Tiirikainen, 2020; Luo et al., 2021). The gene discussed is GSTP1; the disease is lung carcinoma.